{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T14:21:14Z","timestamp":1769869274140,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.3816\/cbc.2007.s.004","type":"journal-article","created":{"date-parts":[[2008,9,11]],"date-time":"2008-09-11T21:04:54Z","timestamp":1221167094000},"page":"S29-S35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"S1","title":["Potential Use of Bisphosphonates in the Prevention of Metastases in Early-Stage Breast Cancer"],"prefix":"10.3816","volume":"7","author":[{"given":"Robert","family":"Coleman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CBC.2007.s.004_bib1","series-title":"GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 5. Version 2.0","author":"Ferlay","year":"2004"},{"key":"10.3816\/CBC.2007.s.004_bib2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-2407-2-37","article-title":"Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000","volume":"2","author":"Shibuya","year":"2002","journal-title":"BMC Cancer"},{"key":"10.3816\/CBC.2007.s.004_bib3","series-title":"SEER Cancer Statistics Review, 1975\u20132001","year":"2004"},{"issue":"suppl 4","key":"10.3816\/CBC.2007.s.004_bib4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1634\/theoncologist.9-90004-14","article-title":"Bisphosphonates: clinical experience","volume":"9","author":"Coleman","year":"2004","journal-title":"Oncologist"},{"key":"10.3816\/CBC.2007.s.004_bib5","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1101\/gad.1449506","article-title":"Genetic regulation of bone mass and susceptibility to osteoporosis","volume":"20","author":"Ralston","year":"2006","journal-title":"Genes Dev"},{"key":"10.3816\/CBC.2007.s.004_bib6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/sj.cr.7290266","article-title":"Mechanisms of cancer metastasis to the bone","volume":"15","author":"Yin","year":"2005","journal-title":"Cell Res"},{"key":"10.3816\/CBC.2007.s.004_bib7","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.bbrc.2004.11.070","article-title":"Crosstalk between cancer cells and bone microenvironment in bone metastasis","volume":"328","author":"Yoneda","year":"2005","journal-title":"Biochem Biopys Res Commun"},{"key":"10.3816\/CBC.2007.s.004_bib8","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra030831","article-title":"Mechanisms of bone metastasis","volume":"350","author":"Roodman","year":"2004","journal-title":"N Eng J Med"},{"key":"10.3816\/CBC.2007.s.004_bib9","first-page":"4432","article-title":"Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden in syngeneic and nude mouse models of experimental bone metastasis","volume":"61","author":"Morony","year":"2001","journal-title":"Cancer Res"},{"key":"10.3816\/CBC.2007.s.004_bib10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density","volume":"89","author":"Lacey","year":"1997","journal-title":"Cell"},{"key":"10.3816\/CBC.2007.s.004_bib11","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nature04524","article-title":"Regulation of cancer cell migration and bone metastasis by RANKL","volume":"440","author":"Jones","year":"2006","journal-title":"Nature"},{"key":"10.3816\/CBC.2007.s.004_bib12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S8756-3282(99)00116-7","article-title":"Bisphosphonates: from the laboratory to the clinic and back again","volume":"25","author":"Russell","year":"1999","journal-title":"Bone"},{"key":"10.3816\/CBC.2007.s.004_bib13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0022-3565(24)38786-5","article-title":"Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates","volume":"296","author":"Dunford","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.3816\/CBC.2007.s.004_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00001813-200501000-00002","article-title":"Preclinical evidence for the effect of bisphosphonates and cytotoxic drugs on tumor cell invasion","volume":"16","author":"Woodward","year":"2005","journal-title":"Anticancer Drugs"},{"key":"10.3816\/CBC.2007.s.004_bib15","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/01.cad.0000175582.01446.6f","article-title":"Combined effects of zoledronic acid and doxorubicin on breast cancer cell invasion in vitro","volume":"16","author":"Woodward","year":"2005","journal-title":"Anticancer Drugs"},{"key":"10.3816\/CBC.2007.s.004_bib16","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1054\/bjoc.2001.1727","article-title":"The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel","volume":"84","author":"Jagdev","year":"2001","journal-title":"Br J Cancer"},{"key":"10.3816\/CBC.2007.s.004_bib17","first-page":"1080","article-title":"Pamidronate induces modifications of circulating angiogenetic factors in cancer patients","volume":"8","author":"Santini","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.3816\/CBC.2007.s.004_bib18","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1124\/jpet.102.035295","article-title":"Novel anti-angiogenic effects of the bisphosphonate compound zoledronic acid","volume":"302","author":"Wood","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.3816\/CBC.2007.s.004_bib19","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0305-7372(02)00095-6","article-title":"The anti-tumour activity of bisphosphonates","volume":"28","author":"Neville-Webbe","year":"2002","journal-title":"Cancer Treat Rev"},{"key":"10.3816\/CBC.2007.s.004_bib20","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/ijc.20602","article-title":"Sequenceand schedule-dependent enhancement of zoledronic acid induced apoptosis by doxorubicin in breast and prostate cancer cells","volume":"113","author":"Neville-Webbe","year":"2005","journal-title":"Int J Cancer"},{"key":"10.3816\/CBC.2007.s.004_bib21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0093-7754(01)90263-5","article-title":"Preclinical studies with zoledronic acid and other bisphosphonates: impact on the bone microenvironment","volume":"28","author":"Mundy","year":"2001","journal-title":"Semin Oncol"},{"key":"10.3816\/CBC.2007.s.004_bib22","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1158\/1078-0432.CCR-03-0325","article-title":"Zoledronic acid inhibits visceral metastases in the 4T1\/luc mouse breast cancer model","volume":"10","author":"Hiraga","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.3816\/CBC.2007.s.004_bib23","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/S0002-9440(10)63239-7","article-title":"Minodronate, a newly developed nitrogen containing bisphosphonate suppresses melanoma growth and improves survival by blocking vascular endothelial growth factor signaling","volume":"165","author":"Yamagishi","year":"2004","journal-title":"Am J Pathol"},{"key":"10.3816\/CBC.2007.s.004_bib24","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1186\/bcr1384","article-title":"Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer","volume":"8","author":"Powles","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"10.3816\/CBC.2007.s.004_bib25","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJM199808063390601","article-title":"Reduction in new metastases in breast cancer with adjuvant clodronate treatment","volume":"339","author":"Diel","year":"1998","journal-title":"N Engl J Med"},{"issue":"14 suppl","key":"10.3816\/CBC.2007.s.004_bib26","first-page":"9","article-title":"Adjuvant clodronate treatment improves the overall survival of primary breast cancer patients with micrometastases to bone marrow -a longtime follow-up","volume":"22","author":"Jaschke","year":"2004","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.3816\/CBC.2007.s.004_bib27","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1080\/02841860410032885","article-title":"Ten-year follow-up of a randomized controlled trial of adjuvant clodronate treatment in node-positive breast cancer patients","volume":"43","author":"Saarto","year":"2004","journal-title":"Acta Oncol"},{"issue":"14 suppl","key":"10.3816\/CBC.2007.s.004_bib28","first-page":"9","article-title":"Adjuvant pamidronate (PMT) therapy for the prevention of bone metastases in breast cancer (BC) patients with four or more positive nodes","volume":"22","author":"Kokufu","year":"2004","journal-title":"Proc Am Soc Clin Oncol"},{"issue":"16 suppl","key":"10.3816\/CBC.2007.s.004_bib29","first-page":"99s","article-title":"Pamidronate as adjuvant treatment for prevention of bone metastases in breast cancer","volume":"23","author":"Jung","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.3816\/CBC.2007.s.004_bib30","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S8756-3282(96)00285-2","article-title":"Clodronate decreases the frequency of skeletal metastases in women with breast cancer","volume":"19","author":"Kanis","year":"1996","journal-title":"Bone"},{"issue":"suppl 1","key":"10.3816\/CBC.2007.s.004_bib31","first-page":"109","article-title":"Oral pamidronate in the prevention and treatment of skeletal metastases in patients with breast cancer","volume":"57","author":"van Holten-Verzantvoort","year":"1997","journal-title":"Medicina Buenos Aire"},{"key":"10.3816\/CBC.2007.s.004_bib32","unstructured":"Data on file. Ciba-Geigy; Summit, NJ."},{"key":"10.3816\/CBC.2007.s.004_bib33","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/415530a","article-title":"Gene expression profiling predicts clinical outcome in breast cancer","volume":"415","author":"Van't Veer","year":"2002","journal-title":"Nature"},{"key":"10.3816\/CBC.2007.s.004_bib34","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0140-6736(05)17947-1","article-title":"Gene expression profiles to predict distant metastasis of lymph node negative primary breast cancer","volume":"365","author":"Wang","year":"2005","journal-title":"Lancet"},{"key":"10.3816\/CBC.2007.s.004_bib35","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1200\/JCO.2005.03.8802","article-title":"Genes associated with breast cancer metastatic to bone","volume":"24","author":"Smid","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.3816\/CBC.2007.s.004_bib36","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/bjc.1987.13","article-title":"The clinical course of bone metastases from breast cancer","volume":"55","author":"Coleman","year":"1987","journal-title":"Br J Cancer"},{"key":"10.3816\/CBC.2007.s.004_bib37","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/(SICI)1097-0215(19960822)69:4<350::AID-IJC19>3.0.CO;2-9","article-title":"Expression of bone sialoprotein in human breast cancer is associated with poor survival","volume":"69","author":"Bellahcene","year":"1996","journal-title":"Int J Cancer"},{"key":"10.3816\/CBC.2007.s.004_bib38","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1200\/JCO.2006.06.1952","article-title":"Bone sialoprotein is predictive of bone metastases in resectable non-small cell lung cancer: a retrospective case-control study","volume":"24","author":"Papotti","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.3816\/CBC.2007.s.004_bib39","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/74999","article-title":"Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord","volume":"6","author":"Honore","year":"2000","journal-title":"Nat Med"},{"key":"10.3816\/CBC.2007.s.004_bib40","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1158\/1078-0432.CCR-05-1933","article-title":"A study of the biological receptor activator of nuclear factor-kappa B ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer","volume":"12","author":"Body","year":"2006","journal-title":"Clin Cancer Res"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820911707984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820911707984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:11:07Z","timestamp":1761513067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820911707984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":40,"alternative-id":["S1526820911707984"],"URL":"https:\/\/doi.org\/10.3816\/cbc.2007.s.004","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential Use of Bisphosphonates in the Prevention of Metastases in Early-Stage Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3816\/CBC.2007.s.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}